Articles > Popular publications > Business Wire press releases > October-December 2007 > Tuesday, October 23

Article: Jury Rules Roche Infringes Amgen's EPO Patents.

Article from:
Business Wire
Article date:
October 23, 2007
Copyright

THOUSAND OAKS, Calif. -- Amgen (NASDAQ:AMGN) announced today that a jury in the U.S. Federal District Court in Boston ruled that Roche's pegylated-erythropoietin (peg-EPO) product MIRCERA infringes 11 Amgen EPO patent claims.

Amgen is pleased with the jury's verdict and will now seek an injunction to prevent Roche from commercializing its peg-EPO product in the United States in violation of Amgen's affirmed patent rights. The injunction hearing is scheduled for Nov. 15, 2007.

In addition to infringing its EPO patents, Amgen firmly believes Roche's peg-EPO product provides no clinical or patient benefit over Amgen's innovative therapies, EPOGEN[R] ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Sunlight Research™, Releases Its Amgen EPO ...
Biotech Week;  September 30, 2009 ;     700+ words ... ... US patents owned or controlled by Amgen (NASDAQ:AMGN), and explains ... biologicals, such as EPO." Sunlight's Amgen EPO patents report includes a detailed breakdown ... activity limitations relating to Amgen's Epogen drug. The report provides ...

Article: Genetics Institute files suit against Amgen relating to ...
PR Newswire;  October 29, 1987 ;     700+ words ...GENETICS INSTITUTE FILES SUIT AGAINST AMGEN RELATING TO EPO PATENTS CAMBRIDGE, Mass., Oct. 29 /PRNewswire ... announced that it has filed suit against Amgen, Inc. and Kirin-Amgen, Inc. for infringement of its U.S. Patent ...

Article: Sunlight Research(TM), Releases Its Amgen EPO ...
PR Newswire;  September 14, 2009 ;     700+ words ... ... US patents owned or controlled by Amgen , and explains how those patents ... biologicals, such as EPO." Sunlight's Amgen EPO patents report includes a detailed breakdown ... activity limitations relating to Amgen's Epogen drug. The report provides ...

Article: Amgen Suing Roche For Infringing On EPO ...
BIOWORLD Today;  November 10, 2005 ;     700+ words ... ... strike to protect its anemia drug Epogen, Amgen Inc. filed a lawsuit against F. Hoffmann ... shut out of the U.S. market because of Amgen's six U.S. patents. That's why ... erythropoiesis receptor activator). But Amgen does not believe that CERA is distinct ...

Article: Court Rules in Amgen's Favor in TKT Litigation; Affirms ...
Business Wire;  October 15, 2004 ;     575 words ...THOUSAND OAKS, Calif. -- Amgen, Inc. (NASDAQ:AMGN), the world ... Pharmaceuticals Inc. The Court found Amgen's patent claims valid and infringed ... with earlier decisions, is that four Amgen patents on erythropoietin have been held ...

Article: Court affirms four Amgen EPO patents.
Pharma Marketletter;  October 13, 2008 ;     662 words ... ... 10 claims of four of biotechnology major Amgen's erythropoietin patents. The Court also ruled that Amgen is entitled to a permanent injunction prohibiting ... Court upheld the validity of claim 1 of Amgen's US Patent No 5,955,422 that claims ...

Article: Court rules in Amgen's favor, affirms validity of ...
Biotech Business Week;  November 15, 2004 ;     576 words ... ... NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN), announced that Judge ... Pharmaceuticals, Inc. The court found Amgen's patent claims valid and infringed by ... coupled with earlier decisions, is that four Amgen patents on erythropoietin have been held ...

Article: Jury Rules Roche Infringe Amgen's EPO ...
Biopharm International;  December 1, 2007 ;     322 words ... ... erythropoietin (pegEPO) product, Mircera, infringes 11 Amgen EPO patent claims. Amgen (Thousand Oaks,CA) will now seek an injunction ... of an appearand maintains its position that all of Amgen's patents for epoetin asserted against Roche are ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives